Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

NCT07410676
Recruiting
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/2 · China · 1 site
Registry update: 18 Feb 2026
NCT07221942
Recruiting
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
Phase 2 · United States · 1 site
Registry update: 19 Feb 2026
NCT07390617
Recruiting
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Not applicable · United States · 7 sites
Registry update: 29 May 2026
2025-523620-44-02
Recruiting
BudapestICIVasc: Cardiovascular side effects of immune checkpoint inhibitor oncological therapies and their monitoring in the context of onco-cardiology
Phase 4 · Hungary · 1 site
Registry update: 14 Jan 2026
NCT06041503
Recruiting
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Phase 2 · United States · 1 site
Registry update: 13 Aug 2026
NCT07183319
Recruiting
Circulating Tumor DNA Response In Urothelial Cancer
Phase 2 · United States · 1 site
Registry update: 2 Feb 2026
NCT06417190
Recruiting
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
Phase 2 · United States · 1 site
Registry update: 6 Aug 2026
NCT06733363
Recruiting
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Phase 2 · United States · 1 site
Registry update: 17 Sept 2026
NCT07452432
Recruiting
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Not applicable · South Korea · 1 site
Registry update: 5 Mar 2026
NCT07339761
Recruiting
Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
Not applicable · Denmark · 1 site
Registry update: 14 Jan 2026
NCT07234968
Recruiting
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Not applicable · United States · 2 sites
Registry update: 17 Feb 2026
NCT05962541
Recruiting
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
Phase 4 · Italy · 1 site
Registry update: 31 Dec 2025
NCT07265947
Recruiting
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Phase 2 · Bulgaria, Spain, France, Israel, United States · 42 sites
Registry update: 2 Nov 2026
2023-507307-64-00
Recruiting
Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to avoid secondary resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)
Phase 4 · Italy · 1 site
Registry update: 20 Feb 2024
NCT07285044
Recruiting
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 · United States · 1 site
Registry update: 30 Sept 2026
NCT07218380
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Australia, Brazil, Canada, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Hungary, Italy, Japan, South Korea, Netherlands, Poland, Taiwan, United States · 276 sites
Registry update: 7 Oct 2026
NCT07222488
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Phase 1/2 · Austria, Belgium, Canada, Spain, France, Greece, Israel, Italy, Netherlands, Norway, Türkiye, United States · 17 sites
Registry update: 10 Nov 2026
NCT07307456
Recruiting
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
Phase 2 · China · 1 site
Registry update: 21 Jul 2026
NCT07283835
Recruiting
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Phase 2 · China · 14 sites
Registry update: 23 Apr 2026
NCT06524544
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Phase 3 · United States · 163 sites
Registry update: 4 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.